Human Papillomavirus Infection and Cervical Cancer Prevention in Japan and Korea

Vaccine

Volumn 26, Issue SUPPL. 12, 2008, Pages

  Konno, Ryo ^a   Shin, Hai Rim ^b,c   Kim, Young Tak ^d   Song, Yong Sang ^e   Sasagawa, Toshiyuki ^f   Inoue, Masaki ^f   Park, Jong Sup ^g  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b National Cancer Center   (South Korea)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^d University of Ulsan   (South Korea)

^e Seoul National University   (South Korea)

^f KANAZAWA UNIVERSITY   (Japan)

^g The Catholic University of Korea   (South Korea)

Author keywords

Asia Pacific; Cervical cancer; HPV; HPV vaccine; Japan; Korea; Screening

Indexed keywords

WART VIRUS VACCINE;

AGE DISTRIBUTION; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; DNA DETERMINATION; DRUG INDICATION; FEMALE; HEALTH CARE POLICY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; JAPAN; KOREA; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; VACCINATION; VIRUS INFECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA IN SITU; CHILD; CHILD, PRESCHOOL; DNA, VIRAL; EARLY DETECTION OF CANCER; FEMALE; GUIDELINES AS TOPIC; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; INCIDENCE; INFANT; JAPAN; KOREA; MASS SCREENING; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PREVALENCE; RISK FACTORS; UTERINE CERVICAL NEOPLASMS; VACCINATION; VAGINAL SMEARS; YOUNG ADULT;

EID: 50849132931     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.05.006     Document Type: Article

References (59)

1. Armesto Garcia S, Lapetra Gil ML, Wei L, Kelley E, and Members of the Health Care Quality Indicators (HCQI) Expert Group. Health Care Quality Indicators Project 2006 Data Collection Update Report. OECD Health Working Papers NO. 29; DELSA/HEA/WD/HWP. Paris: Organization for Economic Co-operation and Development; 2007.
2. Curado MP, Edwards B, Shin HR, et al. Cancer Incidence in Five Continents. IARC Scientific Publications No. 160, Lyon, IARC ed. Lyon: IARC, 2007.
3. National Cancer Center. Japanese Cancer Registry Data 2005. Tokyo: Japanese National Cancer Center; 2007.
4. National Cancer Center. Japanese Cancer Registry Data 2005. Annual Incidence of Gynecological Cancers in Japan. Tokyo: National Cancer Center; 2007.
5. Shin H.R., Jung K.W., Won W.J., Kong H.J., Yim S.H., Seo S.W., et al. National Cancer Incidence for the Year 2002 in Korea. Cancer Research and Treatment 39 4 (2007) 139-149
6. Chung H.H., Jang M.J., Jung K.W., Won Y.J., Shin H.R., Kim J.W., et al. Cervical cancer incidence and survival in Korea: 1993-2002. Int J Gynecol Cancer 16 5 (2006) 1833-1838
7. Shin H.R., Park S., Hwang S.Y., Kim J.E., Jung K.W., Won Y.J., et al. Trends in cervical cancer mortality in Korea 1993-2002: corrected mortality using national death certification data and national cancer incidence data. International journal of cancer 122 2 (2008) 393-397
8. Jung K.W., Yim S.H., Kong H.J., Hwang S.Y., Won Y.J., Lee J.K., et al. Cancer survival in Korea 1993-2002: a population-based study. Journal of Korean medical science 22 Suppl (2007) S5-S10
9. de Sanjose S., Diaz M., Castellsagué X., Clifford G., Bruni L., Munoz N., et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 7 7 (2007) 453-459
10. Inoue M., Sakaguchi J., Sasagawa T., and Tango M. The evaluation of human papillomavirus DNA testing in primary screening for cervical lesions in a large Japanese population. Int J Gynecol Cancer 16 (2006) 1007-1013
11. Maehama T. Epidemiological study in Okinawa, Japan, of human papillomavirus infection of the uterine cervix. Infect Dis Obstet Gynecol 13 2 (2005) 77-80
12. Miura S., Matsumoto K., Oki A., Satoh T., Tsunoda H., Yasugi T., et al. Do we need a different strategy for HPV screening and vaccination in East Asia?. Int J Cancer 119 11 (2006) 2713-2715
13. Smith J.S., Lindsay L., Hoots B., Keys J., Franceschi S., Winer R., et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer 121 3 (2007) 621-632
14. Joo W.D., Kim S.H., Kim D.Y., Suh D.S., Kim J.H., Kim Y.M., et al. Prevalence of human papillomavirus infection in Korean women: Risks of abnormal Pap smear and cervical neoplasia. Korean J Gynecol Oncol Colpos 15 4 (2004) 309-316
15. Shin H.R., Lee D.H., Herrero R., Smith J.S., Vaccarella S., Hong S.H., et al. Prevalence of human papillomavirus infection in women in Busan, South Korea. Int J Cancer 103 3 (2003) 413-421
16. Shin H.R., Franceschi S., Vaccarella S., Roh J.W., Ju Y.H., Oh J.K., et al. Prevalence and determinants of genital infection with papillomavirus, in female and male university students in Busan, South Korea. J Infect Dis 190 3 (2004) 468-476
17. Oh J.K., Ju Y.H., Franceschi S., Quint W., and Shin H.R. Acquisition of new infection and clearance of type-specific human papillomavirus infections in female students in Busan, South Korea: a follow-up study. BMC Infect Dis 8 (2008) 13
18. Oh JK, Freanceschi S, Kim BK, Kim JY, Hong EK, Chang YC, et al. Prevalence of human papillomavirus and Chlamydia trachomatis infection among women attending cervical cancer screening in the Republic of Korea. Eur J Cancer Prev 2008; in press.
19. An H.J., Cho N.H., Lee S.Y., Kim I.H., Lee C., Kim S.J., et al. Correlation of cervical carcinoma and precancerous lesions with human papillomavirus (HPV) genotypes detected with the HPV DNA chip microarray method. Cancer 97 7 (2003) 1672-1680
20. Clifford G., Franceschi S., Diaz M., Munoz N., and Villa L.L. Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases. Vaccine 24 Suppl 3 (2006) S26-S34
21. Lee H.S., Kim K.M., Kim S.M., Choi Y.D., Nam J.H., Park C.S., et al. Human papillomavirus genotyping using HPV DNA chip analysis in Korean women. Int J Gynecol Cancer 17 2 (2007) 497-501
22. An H.J., Kim K.R., Kim I.S., Kim D.W., Park M.H., Park I.A., et al. Prevalence of human papillomavirus DNA in various histological subtypes of cervical adenocarcinoma: a population-based study. Mod Pathol 18 (2005) 528-534
23. Cho N.H., An H.J., Jeong J.K., Kang S., Kim J.W., Kim Y.T., et al. Genotyping of 22 human papillomavirus types by DNA chip in Korean women: comparison with cytologic diagnosis. Am J Obstet Gynecol 188 (2003) 56-62
24. Hwang T. Detection and typing of human papillomavirus DNA by PCR using consensus primers in various cervical lesions of Korean women. JKor Med Science 14 (1999) 593-599
25. Hwang T.S., Jeong J.K., Park M., Han H.S., Choi H.K., and Park T.S. Detection and typing of HPV genotypes in various cervical lesions by HPV oligonucleotide microarray. Gynecol Oncol 90 (2003) 51-56
26. Kim Y.B., Jeon Y.T., Seo S.S., Kim J.W., Park N.H., Song Y.S., et al. Prevalence and Genotyping of HPV in Cervical Cancer of Korean Women. Korean J Gynecol Oncol 46 (2003) 789-794
27. Lee J.H., Lee K.H., Lee I.H., Woo H.J., Seong S.J., Kim T.J., et al. Genotyping of Human Papillomavirus Detected with the HPV DNA Chip in Cervical Cancer. Korean J Gynecol Oncol 49 (2006) 858-865
28. Park H.K., Kang Y.M., Park J.M., Choi Y., Kim Y.N., Jeong D.H., et al. Prevalence and Genotyping of HPV in Different Grades of Cervical Intraepithelial Neoplasia and Cervical Cancer. Korean J Gynecol Oncol Colposc 14 (2003) 123-132
29. Park T.C., Kim C.J., Koh Y.M., Lee K.H., Yoon J.H., Kim J.H., et al. Human papillomavirus genotyping by the DNA chip in the cervical neoplasia. DNA Cell Biol 23 (2004) 119-125
30. Wui J.H., Seong H.J., Lee T.S., Oh H.K., Park K.K., and Choi Y.S. The distribution of HPV subtype and multiple HPV infection in cervical cancer and precancerous lesion. Korean J Gynecol Oncol 17 (2006) 39-46
31. Sasagawa T., Dong Y., Saijoh K., Satake S., Tateno M., and Inoue M. Human papillomavirus infection and risk determinants for squamous intraepithelial lesion and cervical cancer in Japan. Jpn J Cancer Res 88 (1997) 376-384
32. Yoshikawa H., Nagata C., Noda K., Nozawa S., Yajima A., Sekiya S., et al. Human papillomavirus infection and other risk factors for cervical intraepithelial neoplasia in Japan. Br J Cancer 80 (1999) 621-624
33. The Ministry of Health and Welfare Research Group. Nationwide Survey on knowledge of HIV/STD and sexual behavior in Japanese people: Epidemiological study on HIV infection. Tokyo: The Ministry of Health and Welfare; 2000.
34. Metropolitan sexual education society of children and students in elementary schools jhsahs. Survey of consciousness and behavior about sex in children and students. Tokyo; 2002.
35. The Ministry of Health Labour and Welfare. Population Movement Investigation. Tokyo: The Ministry of Health, Labour and Welfare; 2008.
36. Muñoz N., Castellsague X., de Gonzalez A.B., and Gissmann L. Chapter 1: HPV in the etiology of human cancer. Vaccine 24 S3 (2006) S1-S10
37. Nagata C., Shimizu H., Yoshikawa H., Noda K., Nozawa S., Yajima A., et al. Serum carotenoids and vitamins and risk of cervical dysplasia from a case-control study in Japan. Br J Cancer 81 (1999) 1234-1237
38. Korean Center for Disease Control and Prevention. Second online survey for the health behavioral factors among adolescents in Korea in 2006. Seoul: Korea Center for Disease Control and Prevention; 2006.
39. Yoo K.Y., Kang D., Koo H.W., Park S.K., Kim D.H., Park N.H., et al. Risk factors associated with uterine cervical cancer in Korea: a case-control study with special reference to sexual behavior. Journal of Epidemiology/Japan Epidemiological Association 7 3 (1997) 117-123
40. Sato S., Matsunaga G., Konno R., and Yajima A. Mass screening for cancer of the uterine cervix in Miyagi Prefecture, Japan. Effects and problems. Acta Cytol 42 2 (1998) 299-304
41. Fujii T., Takehara T., Ohta S., Mukai K., Takahashi C., Tokinaga S., et al. Increased incidence of uterine cervical cancer in young women in Hiroshima prefecture: Necessity of performing uterine cancer screening for women under 29 years old. J Jpn Assoc Cancer Detect 11 (2003) 86-91
42. Yoshida Y., Sato S., Okamura C., Nishino Y., and Yajima A. Evaluating the accuracy of uterine cancer screening with the regional cancer registration system. Acta Cytol 45 (2001) 157-162
43. Cuzick J., Arbyn M., Sankaranarayanan R., Tsu V., Ronco G., Mayrand M.-H., et al. Overview of the evidence from cervical cancer screening studies. Vaccine 26 Suppl 10 (2008) K29-K41
44. The Ministry of Health and Welfare. The First Korean National Health and Nutrition Examination Survey. Seoul: Korea Center for Disease Control; 1998.
45. The Ministry of Health and Welfare. The Second Korean National Health and Nutrition Examination Survey. Seoul: Korea Center for Disease Control and Prevention; 2001.
46. The Ministry of Health and Welfare. The Third Korean National Health and Nutirtion Examination Survey. Seoul: Korea Center for Disease Control; 2005.
47. Shin J.H., Lee J.K., Chough S.Y., Hur J.Y., Park Y.K., and Saw H.S. Hybrid Capture System HPV DNA Test as a Screening Tool of Cervical Cancer. Korean J Gynecol Oncol Colpo 12 1 (2001) 31-38
48. Kim S.J., Park C.K., Lee H.P., Kang S.B., Seo H.S., and Lee J.K. Multi-institutional Study for the Development of Cervical Cancer Screening Model with New Cervicography, Pap Smear and HPV-DNA Test. Korean J Obstet Gynecol 44 5 (2001) 911-937
49. Bernstein S.J., Sanchez-Ramos L., and Ndubisi B. Liquid-based cervical cytologic smear study and conventional Papanicolaou smears: a meta-analysis of prospective studies comparing cytologic diagnosis and sample adequacy. Am J Obstet Gynecol 185 2 (2001) 308-317
50. Kondo K., Ishii Y., Ochi H., Matsumoto T., Yoshikawa H., and Kanda T. Neutralization of HPV16, 18, 31, and 58 pseudovirions with antisera induced by immunizing rabbits with synthetic peptides representing segments of the HPV16 minor capsid protein L2 surface region. Virology 358 (2007) 266-272
51. Matsumoto K., Kawana K., Yoshikawa H., Taketani Y., Yoshiike K., and Kanda T. DNA vaccination of mice with plasmid expressing human papillomavirus 6 major capsid protein L1 elicits typespecific antibodies neutralizing pseudovirions constructed in vitro. J Med Virol 60 (2000) 200-204
52. Sasagawa T., Tani M., Basha W., Rose R.C., Tohda H., Giga-Hama Y., et al. A human papillomavirus type 16 vaccine by oral delivery of L1 protein. Virus Res 110 (2005) 81-90
53. Kim B.G., Lee N.W., Kim S.C., Kim Y.T., Kim Y.M., Kim C.J., et al. Recommendation guideline for Korean Society of Gynecologic Oncology and Colposcopy for quadrivalent human papillomavirus vaccine. Korean J Gynecol Oncol 18 4 (2007) 259-284
54. Kim C.J., Kim B.G., Kim S.C., Kim Y.T., Kim Y.M., Park S.Y., et al. Sexual behavior of Korean young women: preliminary study for the introducing of HPV prophylactic vaccine. Korean J Gynecol Oncol 18 3 (2007) 209-218
55. Sasagawa T., Basha W., Yamazaki H., and Inoue M. High-risk and multiple human papillomavirus infections associated with cervical abnormalities in Japanese women. Cancer Epidemiol Biomarkers Prev 10 1 (2001) 45-52
56. Bao Y.P., Li N., Smith J.S., and Qiao Y.L. Human papillomavirus type distribution in women from Asia: a meta-analysis. Int J Gyn Cancer 18 (2008) 71-79
57. Harper D.M., Franco E.L., Wheeler C.M., Moscicki A.B., Romanowski B., Roteli-Martins C.M., et al. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet 367 9518 (2006) 1247-1255
58. Kim S.G., Hahm M.I., Choi K.S., Seung N.Y., Shin H.R., and Park E.C. The economic burden of cancer in Korea in 2002. European J of Cancer Care (2007) 1-5
59. Han Y.J., Lee S.R., Kang E.J., Kim M.K., Kim N.H., Kim H.J., et al. Knowledge regarding cervical cancer, human papillomavirus and future acceptance of vaccination among in theri late teens in Korea. Korean J Obstet Gynecol 50 8 (2007) 1090-1099